Medirom Healthcare Technologies (MRM) Stock Price, News & Analysis

Company Overview

Medirom Healthcare Technologies Inc. is a Japan-based healthcare and wellness company that provides relaxation, body-care and preventive-health services. Its core business operates under the Re.Ra.Ku brand, a network of studios offering services such as relaxation treatments, stretching and other wellness programs intended to support customers’ physical well-being.

The company also develops digital preventive-healthcare products and services. These initiatives include wearable technology designed to collect health-related data and support ongoing wellness management, including the MOTHER Bracelet, a device marketed as a low-maintenance activity and health-monitoring wearable.

Medirom serves customers primarily in Japan through its physical locations and technology-based healthcare offerings. The company was established in 2000 and began trading on the Nasdaq under the symbol MRM in 2020. Its operations combine in-person wellness services with digital tools intended to encourage preventive healthcare and healthier lifestyles.

Key Stats

• Today's Range: $0.55 to $0.58
• 50-Day Range: $0.54 to $1.08
• 52-Week Range: $0.53 to $2.85
• Volume: 7,889 shs
• Average Volume: 22,934 shs
• Market Capitalization: $15.69 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

Medirom Healthcare Technologies Stock Analysis - MarketRank™

Medirom Healthcare Technologies scored higher than 18% of companies evaluated by MarketBeat, and ranked 465th out of 485 stocks in the consumer discretionary sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.7 / 5
• Analyst Rating: Sell

Consensus Rating

Medirom Healthcare Technologies has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Medirom Healthcare Technologies has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Book Value per Share Ratio

Medirom Healthcare Technologies has a P/B Ratio of 2.40. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.02% of the float of Medirom Healthcare Technologies has been sold short.

Short Interest Ratio / Days to Cover

Medirom Healthcare Technologies has a short interest ratio ("days to cover") of 0.14, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Medirom Healthcare Technologies has recently decreased by 78.62%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Medirom Healthcare Technologies does not currently pay a dividend.

Dividend Growth

Medirom Healthcare Technologies does not have a long track record of dividend growth.

News and Social Media

• Score: 3.1 / 5
• News Sentiment: 0.93

News Sentiment

Medirom Healthcare Technologies has a news sentiment score of 0.93. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.53 average news sentiment score of Consumer Discretionary companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for Medirom Healthcare Technologies this week, compared to 1 article on an average week.

Company Ownership

• Score: 0.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Medirom Healthcare Technologies insiders have not sold or bought any company stock.

Percentage Held by Insiders

40.24% of the stock of Medirom Healthcare Technologies is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Medirom Healthcare Technologies has minimal institutional ownership at this time.

Company Calendar

• Today: 10/10/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Consumer Discretionary
• Industry: Diversified Consumer Services
• Sub-Industry: N/A
• Current Symbol: NASDAQ:MRM
• Previous Symbol: NYSE:MRM
• CIK: 1819704
• Web: medirom.co.jp
• Phone: 81-3-6721-7364
• Fax: N/A
• Employees: 1,051
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $54.89 million
• Price / Sales: 0.29
• Cash Flow: $0.10 per share
• Price / Cash Flow: 5.39
• Book Value: $0.23 per share
• Price / Book: 2.40

Miscellaneous

• Outstanding Shares: 28,390,000
• Free Float: 16,964,000
• Market Cap: $15.69 million
• Optionable: N/A
• Beta: 1.26